Αρχική World News Pimicotinib Shows Robust Antitumour Activity and Clinically Meaningful Improvements in Patients with... World News Pimicotinib Shows Robust Antitumour Activity and Clinically Meaningful Improvements in Patients with Tenosynovial Giant Cell Tumour Από Ogkologos - 18 Μαρτίου, 2026 389 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the MANEUVER study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR Mom Diagnosed With Stage III Breast Cancer While Nursing Her 9-Month-Old... 20 Μαΐου, 2020 Καρκίνος οισοφάγου 22 Ιανουαρίου, 2019 How People With Advanced Cancer Can Find Meaning Toward the End... 25 Ιουλίου, 2023 Cancer Control in American Indian and Alaska Native Populations: A Conversation... 25 Απριλίου, 2018 Φόρτωση περισσοτέρων HOT NEWS What Caregivers Should Know About End-of-Life Care Issues for People With... NCI and CRUK Take on Cancer’s Toughest Problems Treating High-Risk Bladder Cancer and Analyzing PSA Screening for Prostate Cancer:... Nivolumab and Ipilimumab Effective against Melanoma That Has Spread to the...